Soft-tissue sarcomas (STS) have been associated with various rare cancer syndromes and
occur at increased frequencies in survivors of childhood cancer. Also adult patients with STS …

Survival from soft tissue tumors (STTs) has been improved because of the successful
treatment. One of the late sequelae in STT survivors is the development of a second …

Soft tissue sarcomas are rare tumours with infrequent identified aetiological factors. Several
genetic syndromes as well as previous radiation therapy and/or chronic lymphoedema have …

BACKGROUND Modern cancer treatment has increased the survival of patients with various
malignancies substantially. One of the late sequelae of successful treatment is the …

Soft‐tissue sarcomas (STS) account for 1% of adult and 7% of pediatric malignancies.
Histopathology and classification of these rare tumors requires further refinements. The aim …

Recent data from literature show an increase in incidence and mortality due to soft tissue
sarcoma (STS). In the Netherlands age-standardised mortality rates of soft tissue sarcoma …

Objective: Some studies to date have suggested the development of multiple primary
malignancies in patients with soft tissue sarcoma. The current study was performed to …

Soft tissue sarcoma (STS) is one of the most frequent second primary cancer that occurs
during the first 20 years following treatment for a solid cancer in childhood. Our aim was to …

Soft tissue sarcoma (STS) accounts for approximately 1% of all cancers diagnosed annually
in the United States. Population-based data from Connecticut cover-ing the years 1935 …

The role of several potential risk factors in the etiology of soft-tissue sarcoma (STS) was
examined in a hospital-based case-control study, conducted in the Friuli-Vene-zia Giulia …